Sudapyridine (WX-081) in RR-TB Patients
Condition: Rifampicin-resistant Tuberculosis Interventions: Drug: Sudapyridine; Drug: Bedaquiline Sponsor: Shanghai Jiatan Pharmatech Co., Ltd Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials